Annis Gardner Whiting Capital Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.53K	Buy	+36	New	+$4.53K	﹤0.01%	864
2024 Q3	–	Sell	-156	Closed	-$21.5K	–	871
2024 Q2	$21.5K	Buy	156 +11	+8%	+$1.51K	0.01%	553
2024 Q1	$20K	Buy	+145	New	+$20K	0.01%	551